PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms
Molecular Biology Reports · 2024-12 · 51 (1)
DOI: 10.1007/s11033-024-09232-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 15.02.2024. Verfasst von Siyang Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Podocytes, Diabetes Mellitus. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Mitochondrial dysfunction represents a pivotal aspect of the pathogenesis and progression of diabetic kidney disease (DKD). Central to the orchestration of mitochondrial biogenesis is the peroxisome proliferator-activated receptor γ coactivator 1-α (PGC1-α), a master regulator with a profound impact on mitochondrial function. In the context of DKD, PGC1-α exhibits significant downregulation within intrinsic renal cells, precipitating a cascade of deleterious events. This includes a reduction in mitochondrial biogenesis, heightened levels of mitochondrial oxidative stress, perturbed mitochondrial dynamics, and dysregulated mitophagy. Concurrently, structural and functional abnormalities within the mitochondrial network ensue. In stark contrast, the sustained expression of PGC1-α emerges as a beacon of hope in maintaining mitochondrial homeostasis within intrinsic renal cells, ultimately demonstrating an impressive renoprotective potential in animal models afflicted with DKD. This comprehensive review aims to delve into the recent advancements in our understanding of the renoprotective properties wielded by PGC1-α. Specifically, it elucidates the potential molecular mechanisms underlying PGC1-α's protective effects within renal tubular epithelial cells, podocytes, glomerular endothelial cells, and mesangial cells in the context of DKD. By shedding light on these intricate mechanisms, we aspire to provide valuable insights that may pave the way for innovative therapeutic interventions in the management of DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China.
- NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, People's Republic of China.
- Division of Nephrology, Department of Medicine, The University of Hong Kong, Hong Kong, People's Republic of China.
- Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China. libin85@mail.sysu.edu.cn.
- NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, People's Republic of China. libin85@mail.sysu.edu.cn.
- Department of Nephrology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China. chenwei99@mail.sysu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ye, S., Zhang, M., Tang, S. C. W., Li, B., & Chen, W. (2024). PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms. Molecular Biology Reports, 51(1). https://doi.org/10.1007/s11033-024-09232-y
Vancouver
Ye S, Zhang M, Tang SCW, Li B, Chen W. PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms. Molecular Biology Reports. 2024;51(1). doi:10.1007/s11033-024-09232-y
BibTeX
@article{Ye2024,
author = {Ye, Siyang and Zhang, Meng and Tang, Sydney C W and Li, Bin and Chen, Wei},
title = {PGC1-α in diabetic kidney disease: unraveling renoprotection and molecular mechanisms},
journal = {Molecular Biology Reports},
year = {2024},
volume = {51},
number = {1},
doi = {10.1007/s11033-024-09232-y}
}
EUVIMED